Crescel LLC files Form D for $2 million securities offering
The Florida biotechnology company reported $1.1 million already raised from eight investors as of a first sale date of August 18, 2026.
Crescel LLC, a limited liability company organized in Florida, filed a Form D notice with the Securities and Exchange Commission disclosing an exempt securities offering. The company is listed as a corporation type entity, specifically a limited liability company, formed more than five years ago.1 Its principal place of business is at 8433 Enterprise Circle, Suite 100 Office 115, in Lakewood Ranch, Florida.1
The filing names Peter Joseph Passalacqua Jr. and Richard Thomas Williams as executive officers and directors, both located at 1000 5th Street, Suite 200, in Miami Beach, Florida.1 The company classified its industry as biotechnology under the health care category.1
Crescel reported an aggregate net asset value or revenue range of $1 to $1,000,000.1 The offering claims exemption under Rule 506(b).1 The filing is a new notice with a first sale date of August 18, 2026.1 The company does not intend the offering to last more than one year.1 The securities being offered are classified as equity.1 The filing indicates the offering is not being made in connection with a merger, acquisition, or exchange offer type transaction.
The minimum investment accepted from any outside investor is $100,000.1 The total offering amount is listed as $2,000,000, with $1,100,000 already sold and $900,000 remaining to be sold.1 Eight investors have already invested in the offering.1 The company reported $0 in sales commissions and finders' fees, both listed as estimates.1 Proceeds allocated to executive officers, directors, or promoters were also reported at $0.1
The notice was signed by Richard Williams, President of Crescel LLC, on August 19, 2026.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.